Terrie Curran

Terrie Curran

Former President and Chief Executive OfficeratPhathom Pharmaceuticals· In proxies 2023–2025

Pay in FY2025+38% from the year before · Phathom Pharmaceuticals stock +104.3% the same year

Terrie Curran was paid $4.9M in FY2025 (Dec), up 38%. Phathom Pharmaceuticals stock rose 104.3% that year.

Pay$100 in the stock at the end of FY22 → $148
Pay is from the Summary Compensation Table of each Phathom Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Phathom PharmaceuticalsPublic company · 3 yr
    • Former President and Chief Executive Officer2023 – Present · 3 yrStock in role -38%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?